Outcome of intracerebral hemorrhage associated with different oral anticoagulants

Duncan Wilson, David J. Seiffge, Christopher Traenka, Ghazala Basir, Jan C. Purrucker, Timolaos Rizos, Oluwaseun A. Sobowale, Hanne Sallinen, Shin-Joe Yeh, Teddy Y. Wu, Marc Ferrigno, Rik Houben, Floris H. B. M. Schreuder, Luke A. Perry, Jun Tanaka, Marion Boulanger, Rustam Al-Shahi Salman, Hans R. Jaeger, Gareth Ambler, Clare ShakeshaftYusuke Yakushiji, Philip M. C. Choi, Julie Staals, Charlotte Cordonnier, Jiann-Shing Jeng, Roland Veltkamp, Dar Dowlatshahi, Stefan T. Engelter, Adrian R. Parry-Jones, Atte Meretoja, David J. Werring*, CROMIS-2 Collaborators

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1693-1700
Number of pages8
JournalNeurology
Volume88
Issue number18
DOIs
Publication statusPublished - 2 May 2017

Keywords

  • THROMBIN INHIBITOR DABIGATRAN
  • ATRIAL-FIBRILLATION
  • INTRACRANIAL HEMORRHAGE
  • WARFARIN
  • TRIAL
  • REVERSAL
  • RIVAROXABAN
  • VOLUME
  • IDARUCIZUMAB
  • MANAGEMENT

Cite this